HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever To Appeal NAD Ruling On Suave-Vs-BBW Scent Comparison

This article was originally published in The Rose Sheet

Executive Summary

The National Advertising Division advises Unilever to discontinue preference and parity claims for Suave body-wash scents, compared with Bath & Body Works fragrances, following an advertising challenge from the latter brand’s parent, L Brands. Unilever intends to appeal the verdict.

You may also be interested in...



Suave 'Beautiful As' Bath & Body Works Claim Deemed Puffery In NAD Review

Council of Better Business Bureaus Division review Unilever claims for Suave Essentials on challenge by L Brands, which argued “as beautiful as” is linked to a specific product attribute – fragrance – and expressly compares Unilever's products to Bath & Body Works products. L Brands contended “as beautiful as” is equivalent to claim “as appealing as,” which NAD concluded was unsubstantiated in 2016.

NAD Head Laura Brett On Program Streamlining, Class Action Climate And Mascara Feuds

A Q&A with Laura Brett, four months into her new role as director of the National Advertising Division.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel